CALC NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

CalciMedica, Inc. Common Stock · Healthcare · Biotechnology

Open interactive chart View report data Download investor PDF
Latest close 0.76 USD
3.3% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -45.1% below the Trend Line and sits at 4.4% of its 52-week range. The latest completed week returned 3.3%, after a -6.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal; earnings are due in 13d.

Setup score 28 out of 100
Latest Close 0.76 USD 24 Jul 2026
1W Return 3.3% latest completed week
4W Return -6.9% short-term follow-through
12W Return 29.1% quarterly tape
Trend Breadth 48.1% 25 of 52 weeks active
Volume Ratio 0.2x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 3.3% Latest completed week; four-week move -6.9%. Indicator stack 26/54 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 53/100 40 relevant articles in the latest sentiment read. Event risk 13d Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -45.1% below the Trend Line and sits at 4.4% of its 52-week range. The latest completed week returned 3.3%, after a -6.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.2x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2112-week average 0.09

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.21Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -6.9% over four weeks, 29.1% over 12 weeks, and -80.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W3.3%
4W-6.9%
12W29.1%
26W-85.6%
52W-80.0%
Active trend streak0 weeks
Active weeks in one year25
Trend breadth48.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.38Latest activity-pressure read.
Pressure change-31.0%Four-week change in activity pressure.
Leadership-70.15Latest relative-leadership reading.
RS change1.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 58% Model confidence 55%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength68/100Blend of value, momentum, and quality. Underlying universe rank 33; rank 1 is best.
Value58/100Relative valuation strength. Underlying universe rank 43; rank 1 is best.
Quality57/100Profitability and accounting quality. Underlying universe rank 44; rank 1 is best.
Momentum59/100Medium-term price momentum. Underlying universe rank 42; rank 1 is best.
Growth59/100Revenue and earnings growth. Underlying universe rank 42; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-262.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
1/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-37.9%
Net share repurchases relative to market value.
Shareholder yield
-37.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment53/100

Weighted news tone is neutral across 40 relevant articles.

10 positive · 26 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings13dNext report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-89.4%Distance below the 52-week high.
13-week volatility15.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+40.8%Week of 6 Mar.
Worst week-82.9%Week of 30 Jan.
Latest week+3.3%Week of 24 Jul.

Shape of recent returns

Strong gains10
Modest gains3
Flat weeks0
Modest losses4
Sharp losses9
Recent vol15.4%13-week weekly-return volatility.
Base vol19.1%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew11.8% / -12.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape25/100

Trend, activity pressure, participation, and risk combine to a 25/100 tape read.

 Indicator analysis28/100

Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.

Activity pressure 0.21; No reversal markers Factors60/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 95 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment53/100

Weighted news tone is neutral across 40 relevant articles.

1 Healthcare Stock to Keep an Eye On and 2 We Avoid Insiders50/100

No recent insider transaction evidence is stored.

 Earnings13d

Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20260.76 USD3.3%1.38 USD3.05 USD0.38-70.151.3MOff
17 Jul 20260.74 USD-20.9%1.57 USD3.07 USD0.52-72.371.8MOff
10 Jul 20260.93 USD-3.7%1.75 USD3.08 USD0.50-67.231.6MOff
3 Jul 20260.97 USD18.3%1.87 USD3.10 USD0.48-65.764.4MOff
26 Jun 20260.82 USD8.0%1.98 USD3.12 USD0.54-71.0361.8MOff
19 Jun 20260.76 USD-12.9%2.09 USD3.14 USD0.44-74.56359.7KOff
12 Jun 20260.87 USD-18.2%2.18 USD3.16 USD0.43-70.331.4MOff
5 Jun 20261.06 USD29.7%2.25 USD3.18 USD0.39-63.243.7MOff
29 May 20260.82 USD29.9%2.32 USD3.21 USD0.18-73.17970.2KOff
22 May 20260.63 USD-4.3%2.39 USD3.24 USD-0.13-78.97405.6KOff
15 May 20260.66 USD4.5%2.47 USD3.25 USD-0.39-78.03843.6KOff
8 May 20260.63 USD6.9%2.55 USD3.27 USD-0.69-79.31534.5KOff
1 May 20260.59 USD0.7%2.64 USD3.28 USD-0.94-79.87702.8KOff
24 Apr 20260.58 USD-3.1%2.72 USD3.30 USD-0.98-79.94790.7KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.